These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6260497)

  • 41. Tc-99m-pertechnetate scanning in metastatic thyroid carcinoma: a case report.
    Lamberigts G; De Roo M; Devos P; Burie D
    Clin Nucl Med; 1981 Apr; 6(4):172-4. PubMed ID: 7214773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solitary thyroid nodules.
    Reschini E; Catania A
    Lancet; 1985 Nov; 2(8466):1237. PubMed ID: 2866307
    [No Abstract]   [Full Text] [Related]  

  • 43. [Thyroid scintigraphy].
    Secades I; Torres M; Arnáiz F; Castell M; La Banda JP
    Rev Esp Med Nucl; 1999 Jun; 18(3):227-30. PubMed ID: 10475736
    [No Abstract]   [Full Text] [Related]  

  • 44. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
    Scott GC; Meier DA; Dickinson CZ
    J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative differences between the thyroid uptake of 123I and 99mTc.
    Siegel JA; Harpen MD; Lee WP; Verma RC; Greenfield MA
    Eur J Nucl Med; 1984; 9(11):494-8. PubMed ID: 6097449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disparate imaging of the autonomous functioning thyroid nodule with 99mTc-pertechnetate and radioiodine.
    Miller JM; Kasenter AG; Marks DS
    Radiology; 1976 Jun; 119(3):737-9. PubMed ID: 935420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effective image diagnosis of thyroid diseases].
    Konishi J
    Nihon Naika Gakkai Zasshi; 1990 Jul; 79(7):852-6. PubMed ID: 2172425
    [No Abstract]   [Full Text] [Related]  

  • 48. Faster assessment of patients receiving unnecessary thyroid treatment: concise communication.
    Stoffer SS; Szpunar WE; Meier DA
    J Nucl Med; 1983 Feb; 24(2):119-22. PubMed ID: 6296335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of radiocontaminants in commercially available iodine-123: dosimetric evaluation.
    Ziessman HA; Fahey FH; Gochoco JM
    J Nucl Med; 1986 Mar; 27(3):428-32. PubMed ID: 3012027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I.
    Caveny SA; Klingensmith WC; Martin WE; Sage-El A; McIntyre RC; Raeburn C; Wolfe P
    J Nucl Med Technol; 2012 Jun; 40(2):104-10. PubMed ID: 22566587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of 99mTc and 123I for thyroid imaging.
    Arnold JE; Pinsky S
    J Nucl Med; 1976 Apr; 17(4):261-7. PubMed ID: 1255250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
    Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E
    J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disparate uptake of 99mTcO4- and 125I- in thyroid cells in culture.
    Eggo MC; Bachrach LK; Mak W; Burrow GN
    Horm Metab Res; 1986 Mar; 18(3):167-72. PubMed ID: 3009293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neck and whole-body scanning with 5-mCi dose of (123)I as diagnostic tracer in patients with well-differentiated thyroid cancer.
    Gulzar Z; Jana S; Young I; Bukberg P; Yen V; Naddaf S; Abdel-Dayem HM
    Endocr Pract; 2001; 7(4):244-9. PubMed ID: 11497474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Scintigraphy of the thyroid gland with technetium 99m pertechnetate].
    Pedersen DM; Petersen G; Dyrbye M
    Ugeskr Laeger; 1986 Jan; 148(3):131-2. PubMed ID: 3006309
    [No Abstract]   [Full Text] [Related]  

  • 56. Evaluation of thyroid scintigraphy in small animals.
    Kaneko M; Kobayashi T; Takano H; Ohnishi T; Kaku T; Nishi T; Kawase C; Kaneko K
    Radioisotopes; 1989 Aug; 38(8):344-6. PubMed ID: 2798958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Scintigraphic evaluation of functional thyroidal autonomy.
    Meller J; Becker W
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S45-51. PubMed ID: 9867196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
    Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidism.
    Wiersinga WM; Touber JL; Trip MD; van Royen EA
    J Clin Endocrinol Metab; 1986 Aug; 63(2):485-91. PubMed ID: 3013921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of technetium-99m pertechnetate in postoperative thyroid carcinoma. A comparative study with iodine-131.
    Khammash NF; Halkar RK; Abdel-Dayem HM
    Clin Nucl Med; 1988 Jan; 13(1):17-22. PubMed ID: 2832116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.